- Record Annual Revenue: Rocket Lab achieved $602 million in 2025 revenue, a 38% YoY growth, with Q4 hitting $180 million (36% YoY increase).
- Backlog Surge: Total backlog reached $1.85 billion at Q4 2025 end, up 73% YoY, driven by the $816 million SDA Tranche III contract.
- Margin Expansion: Q4 2025 reported 38% GAAP and 44% non-GAAP gross margins, reflecting improved operational efficiency.
- Neutron Program Delays: First Neutron launch postponed to Q4 2026 due to Stage 1 tank rupture, with design fixes and testing now prioritized.
- Electron Growth: Launch Services revenue jumped 85% sequentially in Q4 2025, supported by increased Electron mission cadence (every 11–13 days).
Business Highlights and Updates
Rocket Lab achieved several business highlights in Q4 2025, including launching and signing a record number of Electron missions, leading the way on hypersonics testing, and being awarded the largest contract in its history, a $816 million contract to build an advanced constellation of 18 spacecrafts for the Space Development Agency. The company also introduced a space-optimized silicon solar array, enabling low-cost, high-performance power generation in space. As Peter Beck noted, "We're early in the data center space, but we've been developing silicon arrays and power solutions for mega constellations."
Neutron Program Update
The Neutron program made significant progress, with major structures and subsystems passing qualification. The vehicle is now in its final integration phase, which includes hot fire stage tests, wet dress, and launch. Although the Stage 1 tank ruptured during a hydrostatic pressure test, the company has rectified the issue and is making design changes to introduce more margin and improve manufacturability. The first launch is now targeted for Q4 2026.
Guidance and Outlook
The company expects revenue growth of 7% quarter-on-quarter in Q1 2026, with revenue ranging between $185 million and $200 million. GAAP gross margin is expected to range between 34% and 36%, while non-GAAP gross margin is expected to range between 39% and 41%. Adjusted EBITDA loss is expected to range between $21 million and $27 million. Analysts estimate next year's revenue growth at 35.9%, which is slightly lower than the company's historical growth rate.
Valuation Metrics
With a P/E Ratio of -199.59 and an EV/EBITDA of -211.83, the company's valuation metrics indicate that the market is pricing in significant growth expectations. The P/S Ratio of 61.33 also suggests that the company's stock is trading at a premium. However, the company's ROE of -19.23% and ROIC of -8.94% indicate that it is still in a growth phase and investing heavily in its business.